Daily Legal Notices:

Latest News:

 

Search Results

NOTICE OF PUBLIC RULE HEARING The New Mexico Medical Board will convene a regular Board Meeting on Thursday, August 9, 2018 at 8:30 a.m. and Friday, August 10, 2018 at 8:30 a.m. and conduct a Public Rule Hearing on Friday, August 10, 2018 at 10:15 a.m. at the New Mexico Medical Board office conference room, located at 2055 South Pacheco St., Bldg. 400, Santa Fe, NM 87505. The Board will reconvene after the Hearing to take action on the proposed rule amendments. The Board may enter into Executive Session during the meeting to discuss licensing or limited personnel issues. The purpose of the Rule Hearing is to consider repealing and replacing 16.10.10 NMAC (Report of Settlements, Judgements, Adverse Actions and Credentialing Discrepancies) and 16.10.16 NMAC (Administering, Prescribing, and Distribution of Medications). A copy of the proposed amended rule is available upon request from the Board office at 2055 South Pacheco Street, Bldg. 400, Santa Fe, NM 87505, by phone (505) 476-7220, or on the Board's website at www.nmmb.state.nm.us. The hearing will be conducted in accordance with the Medical Practice Act, Section 61-6-5. B NMSA 1978, the Uniform Licensing Act Section 61-1-1 through 61-1-31 NMSA 1978, the State Rules Act, Section 14-4-5.3 NMSA 1978 and other applicable procedures. All interested persons will be given reasonable opportunity at the hearing to submit relevant evidence, data, views or arguments orally or in writing. The New Mexico Medical Board will consider all written comment on the proposed repeal and replacement of 16.10.10 NMAC and 16.10.16 NMAC that is submitted to the Board no later than 5:00 p.m. Thursday, August 9, 2018. Comment must be sent to the New Mexico Medical Board, Attn: Sondra Frank, Esq., Executive Director, 2055 South Pacheco Street, Bldg. 400, Santa Fe, NM 87505. All public comments may be received via mail, electronic mail or fax and will posted the Board's website at www.nmmb.state.nm.us within three days of receipt by the Board. All public comments will be made part of the official rule hearing record. If you are an individual with a disability who is in need of a reader, amplifier, qualified sign language interpreter, or any other form of auxiliary aid or service in order to attend or participate in the meeting or rule hearing, please contact Amanda Quintana at 505-476-7230 or AmandaL.Quintana@state.nm.us prior to the meeting. Public documents, including the agenda and minutes, can be provided in various accessible formats. Please contact the Executive director if a summary or other type of accessible format is needed. NOTICE OF RULEMAKING The New Mexico Medical Board may consider the following items of rulemaking at the meeting: Repeal 16.10.10 NMAC Report of Settlements, Judgements, Adverse Actions and Credentialing Discrepancies 16.10.16 NMAC Administering, Prescribing and Distribution of Medications Replacement 16.10.10 NMAC Report of Settlements, Judgements, Adverse Actions and Credentialing Discrepancies 16.10.16 NMAC Administering, Prescribing and Distribution of Medications 16.10.10 NMAC Report of Settlements, Judgements, Adverse Actions and Credentialing Discrepancies SYNOPSIS: The proposed replacement of 16.10.10 clarifies the intent of part 10 regarding the reporting requirements for licensees, applicants and health care entities. The statutory authority for the New Mexico Medical Board's promulgation of this rule is found in the Medical Practice Act (NMSA 1978, Sections 66-6-1 to -35) and the Impaired Health Care Provider Act (NMSA 1978, Sections 66-1-7 to -12). Specifically, the revision makes clear (a) the board's reporting requirements apply to applicants as well as licensees, (b) applicants and licensees have a duty to report all types of adverse actions, not just those relating to or affecting their competence or clinical privileges, (c) health plans and networks are among the entities that must report actions involving licensees and applicants, (d) licensees and applicants have a duty to report colleagues who are impaired, incompetent or unethical, and (e) licensees and applicants have a duty to self-report to the board if their ability to practice safely or effectively is impaired. 16.10.16 NMAC Administering, Prescribing and Distribution of Medications. SYNOPSIS: The proposed replacement of 16.10.16 updates the intent of part 16 regarding the administering, prescribing and distribution of medications by physician assistants. The statutory authority for the New Mexico Medical Board's promulgation of this rule is found in the Medical Practice Act (NMSA 1978, Sections 66-6-1 to -35). The purpose of amending the Part 16 is to conform the regulations to House Bill 215 2017 statutory amendments. Amongst other things, the PA statutory amendment added "collaboration" as a possible status for PAs and added distribution to PA prescribing abilities. The regulation changes are also necessary because the current rule on PA prescribing reflects requirement which have not been statutorily required for many years, including a formulary, direct physician oversight and limits on prescribing. Specifically, the revisions include a definition of "compounding" and clarifies that Physician Assistants may not compound drugs; any reference to a formulary is deleted; requirements for physician assistant prescription pads is deleted; and limitations to prescribing by physician assistants is added. Journal: July 12, 2018 Left-red    Print Legal   Email-red   Published on: Thu July 12, 2018